Variant report

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr9:101187045..101191068-chr9:101192266..101195284,5	K562	blood:
2	chr9:101183187..101185622-chr9:101190369..101193309,2	K562	blood:

rSNPs within LD-proxies of this variant (count:21)

rs_ID	r²[population]
rs10986192	0.93[AFR][1000 genomes];0.97[AMR][1000 genomes];0.91[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs10986247	0.83[AFR][1000 genomes];0.98[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs10986473	1.00[CHB][hapmap];1.00[ASN][1000 genomes]
rs11793304	0.87[CEU][hapmap];1.00[CHB][hapmap];0.80[MEX][hapmap];1.00[ASN][1000 genomes]
rs1211545	1.00[ASN][1000 genomes]
rs12343226	1.00[ASN][1000 genomes]
rs13286162	1.00[ASN][1000 genomes]
rs13288889	1.00[ASN][1000 genomes]
rs1572473	0.85[AFR][1000 genomes];0.95[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs16917637	1.00[CHB][hapmap];1.00[ASN][1000 genomes]
rs17770838	1.00[CHB][hapmap];1.00[ASN][1000 genomes]
rs2900382	1.00[ASW][hapmap];0.83[CEU][hapmap];1.00[CHB][hapmap];0.90[GIH][hapmap];0.92[LWK][hapmap];0.93[MEX][hapmap];0.87[MKK][hapmap];0.85[TSI][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];0.88[AMR][1000 genomes];0.86[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs57185876	1.00[ASN][1000 genomes]
rs57905636	1.00[ASN][1000 genomes]
rs59614727	1.00[ASN][1000 genomes]
rs60868407	0.90[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs66989623	0.93[AFR][1000 genomes];0.98[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs73502480	1.00[ASN][1000 genomes]
rs7860298	1.00[CHB][hapmap];1.00[ASN][1000 genomes]
rs7861148	1.00[CHB][hapmap];1.00[ASN][1000 genomes]
rs871744	1.00[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:4 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv430085	chr9:100928245-101339645	Flanking Active TSS Enhancers Weak transcription Genic enhancers Strong transcription Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
2	nsv831664	chr9:101024862-101205637	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS ZNF genes & repeats Genic enhancers Strong transcription Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases
3	nsv831665	chr9:101170061-101367692	Enhancers Weak transcription ZNF genes & repeats Bivalent Enhancer Flanking Active TSS Genic enhancers Strong transcription Active TSS	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
4	nsv614936	chr9:101182698-101680380	Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Strong transcription Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	21 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:6 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:101180800-101191800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
2	chr9:101181600-101192600	Weak transcription	Cortex derived primary cultured neurospheres	brain
3	chr9:101188000-101193000	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
4	chr9:101190400-101191800	Weak transcription	Muscle Satellite Cultured Cells	--
5	chr9:101190400-101191800	Weak transcription	Osteobl	bone
6	chr9:101190600-101190800	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived

Quick Search: